NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q4 2025

Type / Class
Equity / Ordinary Shares, no par value per share
Symbol
NVCR on Nasdaq
Shares outstanding
112,245,592
Price per share
$13.80
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
95,426,360
Total reported value
$1,234,197,201
% of total 13F portfolios
0%
Share change
+4,449,655
Value change
+$57,588,881
Number of holders
235
Price from insider filings
$13.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.3% $168,501,151 9,083,620 BlackRock, Inc. 31 Mar 2025
Soleus Capital Master Fund, L.P. 7.6% -11% $116,443,577 -$15,208,926 8,530,665 -12% Soleus Capital Master Fund, L.P. 31 Dec 2025
Capital World Investors 1.8% -65% $25,840,000 -$56,626,396 2,000,000 -69% Capital World Investors 30 Sep 2025

As of 31 Dec 2025, 235 institutional investors reported holding 95,426,360 shares of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR). This represents 85% of the company’s total 112,245,592 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 16,796,979 +0.16% 0.01% $217,184,938
BlackRock, Inc. 12% 13,541,448 -2.9% 0% $175,090,922
VANGUARD GROUP INC 9.8% 10,958,209 +4.8% 0% $141,689,643
Soleus Capital Management, L.P. 7.6% 8,530,665 -12% 4.7% $110,301,498
MORGAN STANLEY 4.5% 5,069,895 +453% 0% $65,553,743
STATE STREET CORP 2.3% 2,577,239 -1.3% 0% $33,323,700
GEODE CAPITAL MANAGEMENT, LLC 2.2% 2,476,646 +0.07% 0% $32,028,911
Quantinno Capital Management LP 1.8% 2,010,248 +32% 0.05% $25,992,507
RENAISSANCE TECHNOLOGIES LLC 1.2% 1,387,754 +29% 0.03% $17,943,659
Palo Alto Investors LP 1.2% 1,298,964 +3.4% 2.3% $16,795,605
Nuveen, LLC 1.1% 1,273,349 -25% 0% $16,464,403
JACOBS LEVY EQUITY MANAGEMENT, INC 1.1% 1,223,755 +1093% 0.06% $15,823,152
GOLDMAN SACHS GROUP INC 1% 1,178,045 +30% 0% $15,232,122
BAILLIE GIFFORD & CO 1% 1,121,274 -0.25% 0.01% $14,498,073
AMERICAN CENTURY COMPANIES INC 0.93% 1,041,532 -15% 0.01% $13,467,009
SCHRODER INVESTMENT MANAGEMENT GROUP 0.91% 1,019,969 +129% 0.01% $13,483,990
C WorldWide Group Holding A/S 0.87% 971,784 0% 0.22% $12,565,000
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 0.83% 927,400 0.02% $11,991,282
Point72 Asset Management, L.P. 0.8% 900,496 +672% 0.02% $11,643,413
ALGERT GLOBAL LLC 0.78% 878,998 +29% 0.18% $11,365,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.78% 876,816 -3.7% 0% $11,337,231
NORTHERN TRUST CORP 0.77% 858,986 -4.3% 0% $11,106,689
D. E. Shaw & Co., Inc. 0.73% 822,385 +69% 0.01% $10,633,438
DIMENSIONAL FUND ADVISORS LP 0.67% 752,143 +33% 0% $9,726,934
SILVERCREST ASSET MANAGEMENT GROUP LLC 0.63% 707,609 +0.22% 0.06% $9,149,384

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 95,426,360 $1,234,197,201 +$57,588,881 $12.93 235
2025 Q3 91,721,734 $1,185,106,020 -$66,176,848 $12.92 242
2025 Q2 94,465,807 $1,681,500,579 -$12,863,892 $17.80 238
2025 Q1 95,188,552 $1,696,317,176 +$20,032,618 $17.82 224
2024 Q4 91,572,450 $2,728,943,845 -$6,464,722 $29.80 236
2024 Q3 92,870,663 $1,451,669,038 -$11,191,370 $15.63 220
2024 Q2 92,908,941 $1,591,540,722 +$79,622,550 $17.13 229
2024 Q1 89,139,144 $1,393,246,216 -$17,794,761 $15.63 231
2023 Q4 90,513,054 $1,351,320,799 -$31,137,056 $14.93 213
2023 Q3 92,292,343 $1,490,614,876 -$68,391,278 $16.15 219
2023 Q2 90,419,824 $3,752,040,945 +$42,388,515 $41.50 255
2023 Q1 89,476,517 $5,380,865,921 +$285,351,944 $60.14 291
2022 Q4 84,791,322 $6,218,802,349 -$14,733,916 $73.35 292
2022 Q3 83,680,222 $6,357,718,291 +$227,343,238 $75.98 291
2022 Q2 80,381,456 $5,588,033,518 -$44,506,350 $69.50 291
2022 Q1 81,277,607 $6,732,621,045 +$216,637,732 $82.85 293
2021 Q4 79,039,910 $5,935,576,060 +$45,870,200 $75.08 292
2021 Q3 77,530,211 $9,007,824,387 -$79,435,404 $116.17 301
2021 Q2 77,621,320 $17,214,766,292 +$574,320,737 $221.82 351
2021 Q1 75,251,763 $9,945,540,551 +$137,940,262 $132.18 315
2020 Q4 74,207,296 $12,840,473,582 +$248,693,042 $173.04 348
2020 Q3 73,245,441 $8,150,888,382 +$548,147,986 $111.31 272
2020 Q2 69,147,487 $4,099,622,932 -$81,841,604 $59.30 257
2020 Q1 70,405,458 $4,739,588,144 +$74,841,616 $67.34 260
2019 Q4 69,182,535 $5,829,865,247 +$164,443,633 $84.27 256
2019 Q3 66,719,381 $4,988,905,238 +$90,608,393 $74.78 233
2019 Q2 65,861,063 $4,162,579,908 +$194,738,922 $63.23 190
2019 Q1 63,569,972 $3,062,108,451 +$300,901,329 $48.17 195
2018 Q4 57,301,030 $1,918,395,943 +$53,781,587 $33.48 162
2018 Q3 54,688,021 $2,865,670,263 +$204,094,768 $52.40 173
2018 Q2 51,789,754 $1,621,010,556 +$259,146,142 $31.30 159
2018 Q1 44,010,189 $959,322,549 +$148,501,027 $21.80 128
2017 Q4 37,435,567 $756,203,558 +$13,057,344 $20.20 124
2017 Q3 36,815,555 $730,830,514 +$98,783,340 $19.85 103
2017 Q2 31,878,023 $551,480,454 +$204,314,280 $17.30 83
2017 Q1 20,224,271 $164,053,284 +$27,070,509 $8.10 68
2016 Q4 20,282,026 $159,204,948 +$10,262,044 $7.85 73
2016 Q3 18,826,170 $160,713,151 -$21,836,369 $8.54 62
2016 Q2 19,435,597 $226,808,591 +$67,471,069 $11.67 65
2016 Q1 13,616,633 $196,972,145 +$32,373,235 $14.48 56
2015 Q4 11,312,689 $249,219,971 +$248,824,971 $22.36 47